Westchester Capital Management (New York)’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Westchester Capital Management (New York)’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-257,368	Closed	-$9M	–	287
2024 Q1	$9M	Buy	+257,368	New	+$9.39M	0.33%	48

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Westchester Capital Management (New York)'s INBX Position: Q2 2024 in Review

Westchester Capital Management (New York) sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 257,368 shares — an estimated $9M sold.

Westchester Capital Management (New York) first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $9M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Westchester Capital Management (New York) reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Westchester Capital Management (New York) sold 257,368 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $9M.
Westchester Capital Management (New York) first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Westchester Capital Management (New York)'s Inhibrx, Inc. Common Stock position peaked at $9M in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.